---
$id: https://graph.org.ai/products/commodity/51152001
$type: Product
source: UNSPSC
code: "51152001"
title: "Atracurium"
class: "51152000"
classTitle: "Neuromuscular blocking agents"
family: "51150000"
familyTitle: "Autonomic nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Atracurium

**UNSPSC Code**: 51152001
**Class**: [Neuromuscular blocking agents](Neuromuscular blocking agents.mdx)
**Family**: [Autonomic nervous system drugs](../Autonomic nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a neuromuscular blocking agent with the molecular formula C65H82N2O18S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 40AX66P76P, chemically known as benzenesulfonate;5-[3-[1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propanoyloxy]pentyl3-[1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-2-methyl-3,4-dihydro-1H-isoquinolin-2-ium-2-yl]propanoate but generally known as atracurium besylate, which bears US NIH Compound Identifier 47320. European Medicines Agency schedules Atracurium Besylate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB29313. The term ATRACURIUM BESYLATE is an International Non-Proprietary Name or INN. ATRACURIUM BESYLATE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. As of Q4 2014, ATRACURIUM remains the US FDA Preferred Term for this commodity. Atracurium bears US NLM identifiers UMLS ID C0004234 and NCI Concept Code C76068. SMILES: C[N+]1(CCC2=CC(=C(C=C2C1CC3=CC(=C(C=C3)OC)OC)OC)OC)CCC(=O)OCCCCCOC(=O)CC[N+]4(CCC5=CC(=C(C=C5C4CC6=CC(=C(C=C6)OC)OC)OC)OC)C.C1=CC=C(C=C1)S(=O)(=O)[O-].C1=CC=C(C=C1)S(=O)(=O)[O-].

